Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 14.14 CNY -3.81% Market Closed
Market Cap: 31.4B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Relative Value

The Relative Value of one Yili Chuanning Biotechnology Co Ltd stock under the Base Case scenario is 18.06 CNY. Compared to the current market price of 14.14 CNY, Yili Chuanning Biotechnology Co Ltd is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
18.06 CNY
Undervaluation 22%
Relative Value
Price
Y
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
Median 3Y
4.3
Median 5Y
4.3
Industry
8.1
Forward
5.1
vs History
19
vs Industry
Median 3Y
19.9
Median 5Y
19.9
Industry
23
Forward
20.6
vs History
7
vs Industry
Median 3Y
10.9
Median 5Y
10.9
Industry
23.4
vs History
24
vs Industry
Median 3Y
-31.9
Median 5Y
-31.9
Industry
27.3
vs History
0
vs Industry
Median 3Y
3.3
Median 5Y
3.3
Industry
2.6
vs History
12
vs Industry
Median 3Y
4.5
Median 5Y
4.5
Industry
8.1
Forward
5.2
vs History
19
vs Industry
Median 3Y
13.9
Median 5Y
13.9
Industry
9.6
vs History
19
vs Industry
Median 3Y
16.7
Median 5Y
16.7
Industry
4.3
Forward
12.9
vs History
19
vs Industry
Median 3Y
16.7
Median 5Y
16.7
Industry
3.8
Forward
16.9
vs History
12
vs Industry
Median 3Y
11.1
Median 5Y
11.1
Industry
6
vs History
16
vs Industry
Median 3Y
12.5
Median 5Y
12.5
Industry
3.8
vs History
0
vs Industry
Median 3Y
2.6
Median 5Y
2.6
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Yili Chuanning Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
31.5B CNY 5.6 23.9 19.9 19.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average P/E: 180.5
23.9
120%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average EV/EBITDA: 18.1
19.9
164%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Average EV/EBIT: 22.7
19.9
113%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top